Search results
Dr. Eric Padron is an associate member in the in the Department of Malignant Hematology, and the Cancer Biology and Molecular Medicine Programs. In addition, Dr. Padron is the Scientific Director of Malignant Hematology.
- (103)
- Eric.Padron@moffitt.org
Activités. Éditeur, écrivain. modifier - modifier le code - modifier Wikidata. Éric Poindron, né le 20 février 1966 à Reims 1, est un écrivain, éditeur, critique, animateur d'atelier d'écriture et de création littéraire ( université de Reims Champagne-Ardenne ), plasticien, créateur et scénographe d'exposition.
Eric Padron, MD is an Associate Member and Scientific Director of the Department of Hematology at Moffitt Cancer Center (MCC). He completed a hematology oncology fellowship and was recruited to MCC in 2013. Dr.
Blood, The Journal of the American Society of Hematology 125 (12), 1857-1865. , 2015. 185. 2015. GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. E Padron, JS Painter, S Kunigal, AW Mailloux, K McGraw, JM McDaniel, ...
Our laboratory studies the molecular pathogenesis of Chronic myelomonocytic leukemia (CMML) with the goal of identifying novel therapeutic vulnerabilities. CMML is a rare and lethal hematopoietic malignancy characterized by a characteristic classical monocytosis and a propensity to transform to Acute Myeloid Leukemia (AML). Interestingly, the ...
11 - 20 Years of Experience. Practices at. a U.S. News Best Hospital. Book an appointment. Book Online. 1-813-669-0154. Accepting New Patients. H. Lee Moffitt Cancer Center and Research Institute ...
Other Disease Area (s) of Focus: CMML. Dr. Eric Padron is a junior investigator, having completed his fellowship in hematology/oncology at the Moffitt Cancer Center in Florida. He describes his area of interest in bone marrow failure disease as focused on Chronic Myelomonocytic Leukemia (CMML), which is related to Myelodysplastic Syndromes (MDS).
